| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E318213DF29 |
| P698 | PubMed publication ID | 21403590 |
| P2093 | author name string | Li Li | |
| Minnie M Sarwal | |||
| Szu-Chuan Hsieh | |||
| Valeriya Zarkhin | |||
| Patricia A Lovelace | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rituximab | Q412323 |
| P304 | page(s) | 1010-1018 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients. | |
| P478 | volume | 91 |
| Q38306136 | A systematic review of the use of rituximab as induction therapy in renal transplantation |
| Q42280145 | Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience |
| Q50897404 | Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients. |
| Q38392458 | Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management |
| Q56890337 | B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy |
| Q42221525 | B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. |
| Q42234521 | BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. |
| Q64097475 | Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing |
| Q40028756 | Dynamic changes of B-cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection |
| Q89965614 | Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts |
| Q45444391 | Elevated serum levels of B-cell activating factor in pediatric renal transplant patients |
| Q38187170 | Induction of transplantation tolerance through regulatory cells: from mice to men. |
| Q38118894 | Is rituximab effective in childhood nephrotic syndrome? Yes and no. |
| Q85962440 | Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study |
| Q38812385 | Pediatric kidney transplantation: a historical review |
| Q35998928 | RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial |
| Q41527816 | Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. |
| Q37704938 | The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. |
| Q36563918 | The paradoxical functions of B cells and antibodies in transplantation |
Search more.